Brynjelsen Sean
- SEC CIK
- 0001669976
In the past year, 2 open-market sale filings worth $9.91M and no purchases.
Current role at each company
- ETON Eton Pharmaceuticals, Inc.President & CEOas of Aug 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $9.91M
- 2 filings
- Net
- −$9.91M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Brynjelsen Sean as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 (view filing)6:26 PM ET | Aug 19-20 | 1 day | Brynjelsen SeanPresident & CEO | SSale | −100.0K | $60.88 | −$6.09M | −9.4%961.2K after | 4 lots |
| May 29, 2026 (view filing) | May 28 | 1 day | Brynjelsen SeanPresident & CEO | SSale | −120.0K | $31.88 | −$3.83M | −12.6%833.7K after | 2 lots |
| Jun 5, 2025 (view filing) | Jun 3-5 | 2 days | Brynjelsen SeanPresident & CEO | SSale | −210.0K | $17.11 | −$3.59M | −6.8%2.87M after | 5 lots |
| Sep 23, 2022 (view filing) | Sep 22 | 1 day | Brynjelsen SeanChief Executive Officer | PPurchase | +10.0K | $2.10 | +$21.0K | +1.0%1.04M after | |
| Aug 20, 2021 (view filing) | Aug 20 | Same day | Brynjelsen SeanPresident & CEO | PPurchase | +10.0K | $4.32 | +$43.2K | +1.0%1.03M after |